Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer - ScienceDirect
Por um escritor misterioso
Descrição
Enhancer of Zeste Homologue 2 (EZH2) is the catalytic subunit of the polycomb repressive complex 2 (PRC2) that is critical for determining cell identi…
JARID2 and EZH2, the eminent epigenetic drivers in human cancer - ScienceDirect
The molecular mechanisms and therapeutic potential of EZH2 in breast cancer - ScienceDirect
Epigenetic regulation of prostate cancer - ScienceDirect
EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation
BMI1 in the heart: Novel functions beyond tumorigenesis - eBioMedicine
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers - ScienceDirect
EZH2 expression is associated with inferior overall survival in mantle cell lymphoma - Modern Pathology
Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2
Suppression of canonical TGF-β signaling enables GATA4 to interact with H3K27me3 demethylase JMJD3 to promote cardiomyogenesis - Journal of Molecular and Cellular Cardiology
Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction: Trends in Genetics
Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer - Journal of Biological Chemistry
Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity: Trends in Cancer
EZH2 and NF-κB: A context-dependent crosstalk and transcriptional regulation in cancer - ScienceDirect
Epigenetic factors in cancer development: Polycomb group proteins
EZH2 T367 phosphorylation activates p38 signaling through lysine methylation to promote breast cancer progression - ScienceDirect
